{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:00:28Z","timestamp":1782842428660,"version":"3.54.5"},"reference-count":51,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Internet Res"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Telemedicine has the potential to remove geographic and temporal obstacles to health care access. Whether and how telemedicine can increase health care access for underserved populations remains an open question. To address this issue, we integrated facilitated telemedicine encounters for the management of hepatitis C virus (HCV), a highly prevalent condition among people with opioid use disorder (OUD), into opioid treatment programs (OTPs). In New York State, OTPs are methadone-dispensing centers that provide patient-centered, evidence-based treatment for OUD. We investigated the integration and impact of facilitated telemedicine into OTP workflows in these settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aims to understand OTP staff experiences with integrating facilitated telemedicine for HCV treatment into OTPs, including best practices and lessons learned.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted semistructured interviews with 45 OTP staff members (13 clinical, 12 administrative, 6 physicians, and 14 support staff members) at least one year after the implementation of facilitated telemedicine for HCV management. We used hermeneutic phenomenological analysis to understand OTP staff experiences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified 4 overarching themes illustrating the successful integration of facilitated telemedicine for HCV care into OTPs. First, integration requires an understanding of the challenges, goals, and values of the OTP. As OTP staff learned about new, highly effective HCV therapies, they valued an HCV cure as a \u201cwin\u201d for their patients and were excited about the potential to eliminate a highly prevalent infectious disease. Second, the integration of facilitated telemedicine into OTPs fosters social support and reinforces relationships between patients and OTP staff. OTP staff appreciated the ability to have \u201ceyes on\u201d patients during telemedicine encounters to assess body language, a necessary component of OUD management. Third, participants described high levels of interprofessional collaboration as a care team that included the blurring of lines between disciplines working toward a common goal of improving patient care. Study case managers were integrated into OTP workflows and established communication channels to improve patient outcomes. Fourth, administrators endorsed the sustained and future expansion of facilitated telemedicine to address comorbidities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>OTP staff were highly enthusiastic about facilitated telemedicine for an underserved population. They described high levels of collaboration and integration comparable to relevant integrative frameworks. When situated within OTPs, facilitated telemedicine is a high-value application of telemedicine that provides support for underserved populations necessary for high-quality health care. These experiences support sustaining and scaling facilitated telemedicine in comparable settings and evaluating its ability to address other comorbidities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>ClinicalTrials.gov NCT02933970; https:\/\/clinicaltrials.gov\/study\/NCT02933970<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/53049","type":"journal-article","created":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T11:01:57Z","timestamp":1714388517000},"page":"e53049","source":"Crossref","is-referenced-by-count":9,"title":["Care Integration for Hepatitis C Virus Treatment Through Facilitated Telemedicine Within Opioid Treatment Programs: Qualitative Study"],"prefix":"10.2196","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8321-575X","authenticated-orcid":false,"given":"Suzanne S","family":"Dickerson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2135-7952","authenticated-orcid":false,"given":"Saliyah J","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5186-4875","authenticated-orcid":false,"given":"Ana","family":"Ventuneac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9015-5337","authenticated-orcid":false,"given":"Arpan","family":"Dharia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5565-7515","authenticated-orcid":false,"given":"Andrew H","family":"Talal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2024,6,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7326\/M20-2887"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/hex.13854"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31060"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.3692"},{"key":"ref5","unstructured":"Combating hepatitis B and C to reach elimination by 2030: advocacy briefWorld Health Organization2021-07-03https:\/\/apps.who.int\/iris\/handle\/10665\/206453"},{"key":"ref6","unstructured":"Viral hepatitis national strategic plan for the United States: a roadmap to elimination (2021-2025)U.S. Department of Health and Human Services2021-01-19https:\/\/www.hhs.gov\/sites\/default\/files\/Viral-Hepatitis-National-Strategic-Plan-2021-2025.pdf"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2021.106632"},{"key":"ref8","unstructured":"Comparing ways to provide hepatitis C treatment for people who take methadonePatient-Centered Outcomes Research Institute2022-11-22https:\/\/tinyurl.com\/bdhesdjw"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2021.306665"},{"key":"ref10","unstructured":"New York State Office of Addiction Services and SupportsPerson-centered care guidance for OASAS certified programs2021-09-09https:\/\/oasas.ny.gov\/system\/files\/documents\/2020\/01\/oasasperson-centeredcareguidance.pdf"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1089\/tmj.2022.0189"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2013.301611"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s11469-012-9402-5"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2020.103622"},{"key":"ref15","unstructured":"HeathBWise RomeroPReynoldsKACIHS standard framework for levels of integrated healthcareSAMHSA-HRSA Center for Integrated Health Solutions2021-01-03https:\/\/www.thenationalcouncil.org\/wp-content\/uploads\/2020\/01\/CIHS_Framework_Final_charts.pdf?daf=375ateTbd56"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.2452"},{"key":"ref17","author":"Heidegger, M","year":"1962","journal-title":"Being and Time"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijnurstu.2007.09.005"},{"key":"ref19","author":"Heidegger, M","year":"1982","journal-title":"The Question Concerning Technology"},{"key":"ref20","doi-asserted-by":"crossref","DOI":"10.4135\/9781529799583","author":"Dibley, L","year":"2020","journal-title":"Doing Hermeneutic Phenomenological Research: A Practical Guide"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108421"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2648.2006.03898.x"},{"key":"ref23","author":"Ironside, PM","year":"2017","journal-title":"Encyclopedia of Nursing Research, 4th Edition"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1080\/08870449608400256"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1080\/14768320500230185"},{"key":"ref26","first-page":"39","volume":"1","author":"Smith, JA","year":"2004","journal-title":"Qual Res Psychol"},{"key":"ref27","author":"Charmaz, K","year":"2014","journal-title":"Constructing Grounded Theory"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2011.05.011"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.7326\/M20-0132"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.2196\/18488"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.7326\/M20-1814"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.2196\/38176"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis1007"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.24955"},{"key":"ref35","year":"2001","journal-title":"Crossing the Quality Chasm: A New Health System for the 21st Century"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.7326\/M21-3511"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.05.042"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.932306"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa111"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa105"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz633"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2013.07.023"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(21)00471-4"},{"key":"ref44","author":"Totten, AM","year":"2019","journal-title":"Telehealth for Acute and Chronic Care Consultations"},{"key":"ref45","author":"Totten, AM","year":"2016","journal-title":"Telehealth: Mapping the Evidence for Patient Outcomes from Systematic Reviews"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1177\/1357633X18795764"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2014.01.011"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1186\/s40900-023-00474-x"},{"key":"ref49","unstructured":"Overview of opioid treatment program regulations by statePew Charitable Trust2024-01-21https:\/\/www.pewtrusts.org\/en\/research-and-analysis\/issue-briefs\/2022\/09\/overview-of-opioid-treatment-program-regulations-by-state"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1089\/tmj.2022.0534"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.25706"}],"container-title":["Journal of Medical Internet Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jmir.org\/2024\/1\/e53049","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T17:38:21Z","timestamp":1782841101000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jmir.org\/2024\/1\/e53049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,12]]},"references-count":51,"URL":"https:\/\/doi.org\/10.2196\/53049","relation":{"has-preprint":[{"id-type":"doi","id":"10.2196\/preprints.53049","asserted-by":"object"}]},"ISSN":["1438-8871"],"issn-type":[{"value":"1438-8871","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,12]]}}}